June 6 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said on Monday that its shareholders approved the management's proposal to skip dividend distribution for 2021 and to instead retain as reserves last year's net profit of some 24.3 million levs ($13.3 million/12.4 million euro).